Boustead buys 60% of UroMedTech in $6m prostate cancer bet

The $6m investment expands the group's healthcare portfolio.

Boustead Singapore is expanding its healthcare technology business after investing $6m for a 60% stake in Singapore-based medical technology company UroMedTech.

Through Boustead Medical Care Holdings (BMCH), the group added robotic prostate cancer diagnostics to the its healthcare portfolio.

UroMedTech develops UroMaster, a robotic MRI-ultrasound fusion biopsy platform used in prostate cancer diagnosis.

The company said the system has secured regulatory approvals in Singapore, Malaysia, Australia, and other Asian markets, and is deployed across seven hospitals and clinical sites in Singapore, Malaysia, Thailand, and the Philippines.

Boustead said the acquisition will support the commercialisation of UroMaster, the development of new capabilities such as AI-assisted pathology and focal therapy, and expansion into overseas markets through BMCH's regional distribution network.

"We founded the company with a vision of transforming the prostate cancer journey from a fragmented process into a seamless, technology-enabled experience for both clinicians and patients,” said UroMedTech CEO Wilson Gao.

Gao said the company has filed for regulatory approvals in the United States and the European Union and plans to seek approvals in additional markets over the next few years.

Following the acquisition, UroMedTech will continue operating under its existing brand whilst working with BMCH on research and development, clinical partnerships and regulatory approvals.

Boustead said the transaction is not expected to have a material impact on the group's profitability, earnings per share or tangible net asset value per share for the financial year ending 31 March 2027.

A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia